News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Isotechnika Pharma Inc. (ISA.TO)'s NICAM Portfolio Demonstrates Positive Anti-Viral Activity Against Several Important Viruses


11/6/2012 9:31:04 AM

EDMONTON, Alberta, Nov. 6, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") is pleased to announce positive results from the first round of screening of its portfolio of cyclophilin antagonist molecules ("NICAMs") through the contract testing laboratories of the National Institute of Allergy and Infectious Disease ("NIAID"), part of the U.S. National Institutes of Health ("NIH").

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES